DK0622076T3 - Inhibitor for restenose efter perkutan coronar arterioplasti - Google Patents

Inhibitor for restenose efter perkutan coronar arterioplasti

Info

Publication number
DK0622076T3
DK0622076T3 DK93901553.3T DK93901553T DK0622076T3 DK 0622076 T3 DK0622076 T3 DK 0622076T3 DK 93901553 T DK93901553 T DK 93901553T DK 0622076 T3 DK0622076 T3 DK 0622076T3
Authority
DK
Denmark
Prior art keywords
restenosis
percutaneous coronary
inhibitor
substituted
alkyl
Prior art date
Application number
DK93901553.3T
Other languages
English (en)
Inventor
Kazuhisa Kodama
Atsushi Hirayama
Hiroyuki Masayasu
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0622076T3 publication Critical patent/DK0622076T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93901553.3T 1992-01-17 1993-01-14 Inhibitor for restenose efter perkutan coronar arterioplasti DK0622076T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP655292 1992-01-17

Publications (1)

Publication Number Publication Date
DK0622076T3 true DK0622076T3 (da) 1997-06-02

Family

ID=11641498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93901553.3T DK0622076T3 (da) 1992-01-17 1993-01-14 Inhibitor for restenose efter perkutan coronar arterioplasti

Country Status (11)

Country Link
US (1) US5480888A (da)
EP (1) EP0622076B1 (da)
JP (1) JPH05255084A (da)
KR (1) KR100214453B1 (da)
AT (1) ATE150964T1 (da)
CA (1) CA2126465C (da)
DE (1) DE69309435T2 (da)
DK (1) DK0622076T3 (da)
ES (1) ES2100520T3 (da)
GR (1) GR3023308T3 (da)
WO (1) WO1993013762A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
DE69435137D1 (de) 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
WO1996033712A1 (fr) * 1995-04-25 1996-10-31 Daiichi Pharmaceutical Co., Ltd. Remede pour lutter contre le syndrome de l'immunodeficience acquise
CA2223595C (en) * 1995-06-07 2008-08-05 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
TW565558B (en) * 1995-11-09 2003-12-11 Chugai Pharmaceutical Co Ltd Intimal thickening inhibitory agent
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3568775D1 (en) * 1984-06-22 1989-04-20 Nattermann A & Cie S-(carbamoyl-phenylselenyl) derivatives of glutathion and of amino mercaptocarboxylic acids, process for their preparation and pharmaceutical preparations containing them
DE3422962A1 (de) * 1984-06-22 1986-01-02 A. Nattermann & Cie GmbH, 5000 Köln Glutathion-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3443467A1 (de) * 1984-11-29 1986-05-28 A. Nattermann & Cie GmbH, 5000 Köln Mercaptanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3663139D1 (en) * 1985-04-12 1989-06-08 Nattermann A & Cie Diseleno-bis-benzamides of primary and secondary amines, processes for their production and pharmaceutical preparations containing them
DE3626554A1 (de) * 1986-08-06 1988-02-18 Nattermann A & Cie Diselenobis-benzoesaeureamide primaerer heterocyclischer amine, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische praeparate
JP2710633B2 (ja) * 1987-08-28 1998-02-10 第一製薬株式会社 心臓疾患治療剤
JP2596970B2 (ja) * 1988-05-23 1997-04-02 第一製薬株式会社 白血球の粘着又は凝集抑制剤
US5187105A (en) * 1988-07-01 1993-02-16 Miles Inc. Process for determining thiols using chromogenic benzoisothiazolone derivatives
DE3937169A1 (de) * 1989-11-08 1991-05-16 Nattermann A & Cie Benzylselenobenzamide von anilinen und benzylaminen

Also Published As

Publication number Publication date
DE69309435T2 (de) 1997-07-10
CA2126465A1 (en) 1993-07-22
US5480888A (en) 1996-01-02
DE69309435D1 (de) 1997-05-07
JPH05255084A (ja) 1993-10-05
ATE150964T1 (de) 1997-04-15
EP0622076A4 (en) 1994-12-21
EP0622076A1 (en) 1994-11-02
GR3023308T3 (en) 1997-08-29
ES2100520T3 (es) 1997-06-16
CA2126465C (en) 2002-03-05
WO1993013762A1 (en) 1993-07-22
KR100214453B1 (ko) 1999-08-02
EP0622076B1 (en) 1997-04-02

Similar Documents

Publication Publication Date Title
DK0622076T3 (da) Inhibitor for restenose efter perkutan coronar arterioplasti
FI953968A0 (fi) Antraniiliset happojohdannaiset
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
ATE338754T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
DK1258484T3 (da) Nye isoxazol- og thiazolforbindelser og anvendelse deraf som lægemidler
FI943561A (fi) Uudet ainekoostumukset
DE68906183T2 (de) 2'-desoxy-5-fluoruridinderivate.
DE69935718D1 (de) Antidiabetische medikamente
ATE175658T1 (de) 4-alkoxy-2,6-di-t-butylphenolderivate
ATE182331T1 (de) Oxazolidone derivative als monoamine- oxidaseinhibitoren
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ATE283840T1 (de) Chondrogonese promotoren und indolin-2-on derivate
DE60045821D1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
ES2155655T3 (es) Compuestos de benzotiofeno, usos y formulaciones de los mismos.
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
HU9600597D0 (en) 4-alkylthio-pyrimidin-5-yl acetic acid derivates and fungicidal compositions containing them as an active ingredient